Company / Current Assets
Senti Biosciences Holdings, Inc. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$23.3M
FY2025
5-year range
$23.3M / $102.6M
FY2022-FY2025
Trend
-60.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 3 consecutive years, from $103M in FY2022 to $23M in FY2025.
Based on SEC 10-K filings.
$23M in FY2025 with a 3-year CAGR of -39.0%.
Declined from $71M to $23M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -39.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Senti Biosciences Holdings, Inc.'s current assets has declined for 3 consecutive years.
- 3-year CAGR of -39.0%, indicating a declining trend.
- In FY2025, current assets decreased 60.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.3M | -60.5% |
| FY2024 | $59.0M | -17.2% |
| FY2023 | $71.2M | -30.6% |
| FY2022 | $102.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026